Forty years of the war against Ebola

Journal of Zhejiang University: Science B

Volumn 15, Issue 9, 2014, Pages 761-765

  Zhang, Lei ^a   Wang, Hao ^b  

^a Tianjin Joint Academy of Biomedicine and Technology   (China)

^b NANKAI UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EBOLA VACCINE; VIRUS RECEPTOR;

ANIMAL; CLASSIFICATION; EBOLAVIRUS; ECONOMICS; HEMORRHAGIC FEVER, EBOLA; HISTORY; HUMAN; ISOLATION AND PURIFICATION; PANDEMIC; PATHOGENICITY; PHYSIOLOGY; RARE DISEASES;

ANIMALS; EBOLA VACCINES; EBOLAVIRUS; HEMORRHAGIC FEVER, EBOLA; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; PANDEMICS; RARE DISEASES; RECEPTORS, VIRUS;

EID: 84920778504     PISSN: 16731581     EISSN: 18621783     Source Type: Journal    
DOI: 10.1631/jzus.B1400222     Document Type: Article

References (21)

1. Basler, C.F., Amarasinghe, G.K., 2009. Evasion of interferon responses by Ebola and Marburg viruses. J. Interferon Cytokine Res., 29(9):511–520. [doi:10.1089/jir.2009.0076]
2. CDC (US Centers for Disease Control and Prevention), 2014. Ebola outbreaks 2000–2014. Available from http://www.cdc.gov/vhf/ebola/resources/outbreaks.html [Accessed on Aug. 13, 2014].
3. Feldmann, H., 2014. Ebola—a growing threat? New Engl. J. Med., in press. [doi:10.1056/NEJMp1405314]
4. Geisbert, T.W., Jones, S., Fritz, E.A., et al., 2005. Development of a new vaccine for the prevention of Lassa fever. PLoS Med., 2(6):e183. [doi:10.1371/journal.pmed.0020183]
5. Gupta, M., Mahanty, S., Ahmed, R., 2001. Monocyte-derived human macrophages and peripheral blood mononuclear cells infected with Ebola virus secrete MIP-1α and TNF-α and inhibit poly-IC-induced IFN-α in vitro. Virology, 284(1):20–25. [doi:10.1006/viro.2001.0836]
6. Jahrling, P.B., Geisbert, T.W., Geisbert, J.B., et al., 1999. Evaluation of immune globulin and recombinant interferon-α2b for treatment of experimental Ebola virus infections. J. Infect. Dis., 179(S1):S224–S234. [doi:10.1086/514310]
7. Johnson, K.M., Lange, J.V., Webb, P.A., et al., 1977. Isolation and partial characterisation of a new virus causing acute haemorrhagic fever in Zaire. Lancet, 309(8011):569–571. [doi:10.1016/S0140-6736(77)92000-1]
8. Kondratowicz, A.S., Lennemann, N.J., Sinn, P.L., et al., 2011. T-cell immunoglobulin and mucin domain 1 (TIM-1) is a receptor for Zaire Ebolavirus and Lake Victoria Marburgvirus. PNAS, 108(20):8426–8631. [doi:10.1073/pnas.1019030108]
9. Leroy, E.M., Kumulungui, B., Pourrut, X., et al., 2005. Fruit bats as reservoirs of Ebola virus. Nature, 438(7068): 575–576. [doi:10.1038/438575a]
10. Miller, E.H., Obernosterer, G., Raaben, M., et al., 2012. Ebola virus entry requires the host-programmed recognition of an intracellular receptor. EMBO J., 31(8):1947–1960. [doi:10.1038/emboj.2012.53]
11. Mupapa, K., Massamba, M., Kibadi, K., et al., 1999. Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients. J. Infect. Dis., 179(S1): S18–S23. [doi:10.1086/514298]
12. Pettitt, J., Zeitlin, L., Kim, D.H., et al., 2013. Therapeutic intervention of Ebola virus infection in rhesus macaques with the MB-003 monoclonal antibody cocktail. Sci. Transl. Med., 5(199):199ra113. [doi:10.1126/scitranslmed.3006608]
13. Rastogi, J., 2014. Canadians leading anti-Ebola research. Canad. Med. Assoc. J., in press. [doi:10.1503/cmaj.109-4869]
14. Reardon, S., 2014. Ebola treatments caught in limbo. Nature, 511(7511):520. [doi:10.1038/511520a]
15. Report of an International Commission, 1978. Ebola haemorrhagic fever in Zaire, 1976. Bull. World Health Organ., 56(2):271–293.
16. Smith, M., Hensley, L.E., Geisbert, T.W., et al., 2013. Interferon-β therapy prolongs survival in rhesus macaque models of Ebola and marburg hemorrhagic fever. J. Infect. Dis., 208(2):310–318. [doi:10.1093/infdis/jis921]
17. Tekmira Pharmaceuticals Co., 2014. Tekmira receives fast track designation from FDA for its anti-Ebola viral therapeutic. Available from http://investor.tekmirapharm.com/releasedetail.cfm?ReleaseID=830680 [Accessed on Aug. 12, 2014].
18. Wamala, J., Lukwago, L., Malimbo, M., et al., 2010. Ebola hemorrhagic fever associated with novel virus strain, Uganda, 2007–2008. Emerg. Infect. Dis., 16(7):1087–1092. [doi:10.3201/eid1607.091525]
19. WHO (World Health Organization), 2014a. Disease outbreak news. Available from http://www.who.int/csr/don/en/[Accessed on Aug. 15, 2014].
20. WHO (World Health Organization), 2014b. Ebola virus disease. Fact sheet N°103, updated April 2014. Available from http://www.who.int/mediacentre/factsheets/fs103/en/[Accessed on Aug. 12, 2014].
21. WHO (World Health Organization), 2014c. Ethical considerations for use of unregistered interventions for Ebola virus disease (EVD). Available from http://www.who.int/mediacentre/news/statements/2014/ebola-ethical-review-summary/en/ [Accessed on Aug. 13, 2014].